Abstract TP103: The Use of Tissue Plasminogen Activator for Treatment of Acute Ischemic Stroke in Patients With Various Vascular Malformations Appears to be Safe

Introduction: The number of acute ischemic stroke patients who receive IV r-tPA have been shown to be lower than those estimated to be eligible for acute thrombolysis. One potential reason provider...